,,iv #aah? ,,congress #b;d ,session ,h4 ,,res4 #ajid ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #ai1 #bjbd,mr4 ,morelle submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,recogniz+ ! significance ( ,sjgr5's z a s]i\s & sy/emic autoimmune disease & designat+ ,april z ,sjgr5's ,aw>5ess ,mon?4 ,:]eas up to #d1jjj1jjj adults 9 ! ,unit$ ,/ates are liv+ ) ,sjgr5's2 ,:]eas ,sjgr5's is a sy/emic autoimmune disease t affects ! entire body-- 7#a7 symptoms include ext5sive dryness ?r\gh\t ! body1 includ+ ! eyes & m\?1 pr(\nd fatigue1 & *ronic pa92 7#b7 ! av]age age = diagnosis is curr5tly betwe5 ! ages ( #de & #ee1 al?\gh ,sjgr5's c affect all ages2 & 7#c7 ! female-to-male ratio = ,sjgr5's diagnosis is approximately #i3a2 ,:]eas ! cause ( ,sjgr5's is n kn[n1 & !re is no s+le te/ to diagnose ! autoimmune disease2 ,:]eas ,sjgr5's is n easily treat$ & is prim>ily palliative1 ) ov]-!-c\nt] products us$ to manage dryness symptoms along ) (f-label prescriptions = anti-inflammatory & disease-modify+ !rapies2 ,:]eas individuals liv+ ) ,sjgr5's are (t5 subject$ to high] out-(-pocket co/s1 9 ord] to af=d m$ications to control inflammation & dryness1 relieve jo9t1 muscle & n]ve pa91 r$uce acid reflux due to limit$ saliva production1 & treat ! deva/at+ complications ( oral & o!r dryness2 ,:]eas rheumatologi/s prim>ily treat individuals ) ,sjgr5's1 a wide v>iety ( speciali/s are involv$1 includ+ d5ti/s1 neurologi/s1 ocul> speciali/s1 otol>yngologi/s1 ga/ro5t]ologi/s1 nephrologi/s1 & pulmonologi/s1 among o!rs2 ,:]eas ! physical & psy*ological impact ( ,sjgr5's c sev]ely affect an individual's duties at home & 9 ! workplace2 ,:]eas !re is a ne$ to update ! nom5clature to classify ,sjgr5's z a disease2 ,:]eas !re is a ne$ = m rese>* to und]/& ! pa?ology t leads to ! autoimmune attack 9 ,sjgr5's1 includ+ ! role ( ! int]play ( ! immune & n]v\s sy/ems2 ,:]eas cl9ical trials are und]way to te/ ! efficacy ( t>get$ !rapies t w address ! cause ( ,sjgr5's2 ,:]eas rese>* is und]way to id5tify g5es & environm5tal influ5ces t may contribute to und]/&+ :o is susceptible to ,sjgr5's2 & ,:]eas m rese>* is ne$$ to id5tify new !rapies to help individuals ) ,sjgr5's manage ! symptoms & complications z !y age3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 recognizes ! importance ( ,sjgr5's z a s]i\s heal? issue t causes a significant heal? burd52 7#b7 enc\rages ! ,dep>tm5t ( ,heal? & ,human ,s]vices & relevant ag5cies-- 7,a7 to id5tify new areas ( rese>* to improve ! und]/&+ ( ! causes & id5tify biom>k]s t w help ) pati5t /ratification & diagnosis1 disease managem5t1 & developm5t ( t>get$ !rapies = ,sjgr5's pati5ts2 7,b7 to bett] quantify ! numb] ( pati5ts suff]+ f ,sjgr5's z _m are believ$ to be undiagnos$ or are misdiagnos$2 7,c7 to update & dissem9ate lit]ature on ,sjgr5's to public heal? pr(essionals to increase aw>5ess = ! condition2 & 7,d7 to build aw>5ess among physicians & communities 9 und]s]v$ areas s t pati5ts are diagnos$ correctly & obta9 ne$$ c>e4